Brew Ha Ha: The Ongoing Debate About Your Coffee Consumption
April 3, 2024
The debate continues. We’ve previously posted about the many health benefits that appear to be derived from consuming coffee: everything from the boost of mental alertness from the caffeine to the anti-inflammatory protections from the antioxidants in coffee. You can add to that the results of a brand new study…
Testing And Treating: The Latest Updates on Alzheimer’s Dementia
January 31, 2024
Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…
Protect And Defend: Why You Need The Updated COVID Vaccine Now
October 18, 2023
So, have you “armed” yourself with the latest COVID-19 vaccine? As we previously reported, there is a new COVID-19 vaccine that will protect you from the Omicron variants now circulating. The most recent data reports that about 7 million Americans have already rolled up their sleeves and been vaccinated against…
Buzz Cup: Consuming Caffeine As You Get Older
October 18, 2023
Most would agree that there’s nothing like a good cup of coffee, especially to get you going in the morning. In fact, a recent survey of 2000 American coffee drinkers found that 81% of those surveyed said it’s that first cup of the day that motivates them to get out…
Weight And Wonder: Are The New Weight Loss Drugs Right For You?
July 26, 2023
Have you jumped on the weight-loss medication bandwagon yet? Have you wondered whether there’s finally a way for you to shed those extra pounds that have been plaguing you for decades and return to your svelte days of yesteryear? Although we’ve previously told you that a bit of extra weight…
A Hope And A Prayer: Who Will Gain Access To The New FDA-Approved Alzheimer’s Treatment?
July 12, 2023
If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…